GSK3α: An Important Paralog in Neurodegenerative Disorders and Cancer
Open accessThe DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
The biological activity of the enzyme glycogen synthase kinase-3 (GSK3) is fulfilled by two paralogs named GSK3α and GSK3β, which possess both redundancy and specific functions. The upregulated activity of these proteins is linked to the development of disorders such as neurodegenerative disorders (ND) and cancer. Although various chemical inhibitors of these enzymes restore the brain functions in models of ND such as Alzheimer’s disease (AD), and reduce the proliferation and survival of cancer cells, the particular contribution of each paralog to these effects remains unclear as these molecules downregulate the activity of both paralogs with a similar efficacy. Moreover, given that GSK3 paralogs phosphorylate more than 100 substrates, the simultaneous inhibition of both enzymes has detrimental effects during long-term inhibition. Although the GSK3β kinase function has usually been taken as the global GSK3 activity, in the last few years, a growing interest in the study of GSK3α has emerged because several studies have recognized it as the main GSK3 paralog involved in a variety of diseases. This review summarizes the current biological evidence on the role of GSK3α in AD and various types of cancer. We also provide a discussion on some strategies that may lead to the design of the paralog-specific inhibition of GSK3α.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Specific inhibition of GSK3 may be beneficial in acute myeloid leukemia. Left panel: The selective inhibitors BRD-0705, Tivantinib, and others reported by Neuman et al. [89] promote the differentiation of acute myeloid leukemia (AML) cells without the stabilization of β-catenin and without deleterious effects [29,43,90,91]. Right panel: The inhibition of both GSK3 paralogs leads to deleterious effects and promotes β-catenin stabilization and cell proliferation [29,85].](https://figures.cochat.ai/paper-figures/04c9984b78794fa2b8d8c42cf62634cf/gsk3-an-important-paralog-in-neurodegenerative-disorders-and-cancer-figure-2.jpg)
![Figure 3 Molecular docking of GSK3α/β inhibitors. The ligands coupled to the GSK3α simulated protein GSK3β–D133E (white-gray surface) by Autodock Vina are color-coded as follows: 15b [104], golden; EHT1610 [97], green; BRD0705 [29], gray; and Λ-OS1 [96], blue. The arrows point to the region where the ligands interact with the cavity proposed by Wagner et al. [29]. Image generated with Autodock tools 1.5.6.](https://figures.cochat.ai/paper-figures/879abf51ac384a63a59f0d10db4af4da/gsk3-an-important-paralog-in-neurodegenerative-disorders-and-cancer-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As the role of GSK-3α in promoting Aβ production and tau phosphorylation in AD models is recognized”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [496]
The cited source says what the claim attributes to it.
In the citing paper
“selective inhibition of GSK-3α has emerged as a promising therapeutic strategy.494,496,497”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [496]
The cited source says what the claim attributes to it.
In the citing paper
“It is noteworthy that simultaneous inhibition of both GSK-3α and GSK-3β could excessively activate the wnt/β-catenin pathway, leading to abnormal cell proliferation and other detrimental effects.496,498”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [496]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Alzheimer's Disease and the Amyloid-β Peptide
Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
Martin, M., Rehani, K., Jope, R. S., & Michalek, S. M. (2005) · Nature Immunology · doi:10.1038/ni1221 · Cited by 1,080
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Wang, J., Gu, B. J., Masters, C. L., & Wang, Y.-J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.111 · Cited by 808
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774
Systematic Discovery of In Vivo Phosphorylation Networks
Linding, R., Jensen, L. J., Ostheimer, G. J., van Vugt, M. A. T. M., Jørgensen, C., Miron, I. M., Diella, F., Colwill, K., Taylor, L., Elder, K., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.052 · Cited by 735
Frame, S., Cohen, P., & Biondi, R. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00253-2 · Cited by 701
Tau stabilizes microtubules by binding at the interface between tubulin heterodimers
Kadavath, H., Hofele, R. V., Biernat, J., Kumar, S., Tepper, K., Urlaub, H., Mandelkow, E., & Zweckstetter, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504081112 · Cited by 524
Doble, B. W., Patel, S., Wood, G. A., Kockeritz, L. K., & Woodgett, J. R. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.001 · Cited by 448
Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
Ly, P. T. T., Wu, Y., Zou, H., Wang, R., Zhou, W., Kinoshita, A., Zhang, M., Yang, Y., Cai, F., Woodgett, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64516 · Cited by 442
The physics of brain network structure, function and control
Lynn, C. W., & Bassett, D. S. (2019) · Nature Reviews Physics · doi:10.1038/s42254-019-0040-8 · Cited by 400
Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
Takashima, A., Noguchi, K., Sato, K., Hoshino, T., & Imahori, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7789 · Cited by 381
Targeting the untargetable KRAS in cancer therapy
Liu, P., Wang, Y., & Li, X. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.03.002 · Cited by 366
What Are the bona fide GSK3 Substrates?
Sutherland, C. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/505607 · Cited by 345
Tissue-Specific Role of Glycogen Synthase Kinase 3β in Glucose Homeostasis and Insulin Action
Patel, S., Doble, B. W., MacAulay, K., Sinclair, E. M., Drucker, D. J., & Woodgett, J. R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00763-08 · Cited by 260
McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Abrams, S. L., Montalto, G., D'Assoro, A. B., Libra, M., Nicoletti, F., Maestro, R., et al. (2014) · Leukemia · doi:10.1038/leu.2013.184 · Cited by 255
HEMMINGS, B. A., YELLOWLEES, D., C. KERNOHAN, J., & COHEN, P. (1981) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1981.tb05628.x · Cited by 241
Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase Inhibitors
Feng, L., Geisselbrecht, Y., Blanck, S., Wilbuer, A., Atilla-Gokcumen, G. E., Filippakopoulos, P., Kräling, K., Celik, M. A., Harms, K., Maksimoska, J., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja1112996 · Cited by 239
Kerkela, R., Kockeritz, L., MacAulay, K., Zhou, J., Doble, B. W., Beahm, C., Greytak, S., Woulfe, K., Trivedi, C. M., Woodgett, J. R., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36245 · Cited by 235
Glycogen synthase kinase 3 regulates cell fate in dictyostelium
Harwood, A. J., Plyte, S. E., Woodgett, J., Strutt, H., & Kay, R. R. (1995) · Cell · doi:10.1016/0092-8674(95)90458-1 · Cited by 220
Ruel, L., Bourouis, M., Heitzler, P., Pantesco, V., & Simpson, P. (1993) · Nature · doi:10.1038/362557a0 · Cited by 200
Zapata, L., Ding, J., Willing, E.-M., Hartwig, B., Bezdan, D., Jiao, W.-B., Patel, V., Velikkakam James, G., Koornneef, M., Ossowski, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607532113 · Cited by 199
Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
Pandey, M. K., & DeGrado, T. R. (2016) · Theranostics · doi:10.7150/thno.14334 · Cited by 197
Ferrer, I., Barrachina, M., & Puig, B. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0587-8 · Cited by 196
A Common Biological Mechanism in Cancer and Alzheimers Disease?
Behrens, M., Lendon, C., & Roe, C. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486608 · Cited by 184
von Berg, S., Bergh, M., Hellberg, S., Högdin, K., Lo-Alfredsson, Y., Söderman, P., von Berg, S., Weigelt, T., Ormö, M., Xue, Y., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201724m · Cited by 176
The glycine-rich sequence of protein kinases: a multifunctional element
Bossemeyer, D. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90022-1 · Cited by 169
GSK-3α is a central regulator of age-related pathologies in mice
Zhou, J., Freeman, T. A., Ahmad, F., Shang, X., Mangano, E., Gao, E., Farber, J., Wang, Y., Ma, X.-L., Woodgett, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64398 · Cited by 169
Hamann, M., Alonso, D., Martín-Aparicio, E., Fuertes, A., Pérez-Puerto, M. J., Castro, A., Morales, S., Navarro, M. L., del Monte-Millán, M., Medina, M., et al. (2007) · Journal of Natural Products · doi:10.1021/np060092r · Cited by 153
Force, T., & Woodgett, J. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800077200 · Cited by 139
Cavallini, A., Brewerton, S., Bell, A., Sargent, S., Glover, S., Hardy, C., Moore, R., Calley, J., Ramachandran, D., Poidinger, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463984 · Cited by 133
Genetic blueprint of the zoonotic pathogen Toxocara canis
Zhu, X.-Q., Korhonen, P. K., Cai, H., Young, N. D., Nejsum, P., von Samson-Himmelstjerna, G., Boag, P. R., Tan, P., Li, Q., Min, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7145 · Cited by 127
Hurtado, D. E., Molina-Porcel, L., Carroll, J. C., MacDonald, C., Aboagye, A. K., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0889-12.2012 · Cited by 126
Liang, M.-H., & Chuang, D.-M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607468200 · Cited by 126
Identification of the Axin and Frat Binding Region of Glycogen Synthase Kinase-3
Fraser, E., Young, N., Dajani, R., Franca-Koh, J., Ryves, J., Williams, R. S. B., Yeo, M., Webster, M.-T., Richardson, C., Smalley, M. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109462200 · Cited by 115
Repression of GSK3 restores NK cell cytotoxicity in AML patients
Parameswaran, R., Ramakrishnan, P., Moreton, S. A., Xia, Z., Hou, Y., Lee, D. A., Gupta, K., deLima, M., Beck, R. C., & Wald, D. N. (2016) · Nature Communications · doi:10.1038/ncomms11154 · Cited by 115
Wilson, W., & Baldwin, A. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1061 · Cited by 112
GSK3 alpha and GSK3 beta are necessary for axon formation
Garrido, J. J., Simón, D., Varea, O., & Wandosell, F. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.018 · Cited by 109
Palomo, V., Soteras, I., Perez, D. I., Perez, C., Gil, C., Campillo, N. E., & Martinez, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200996g · Cited by 106
Banerji, V., Frumm, S. M., Ross, K. N., Li, L. S., Schinzel, A. C., Hahn, C. K., Kakoza, R. M., Chow, K. T., Ross, L., Alexe, G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci46465 · Cited by 105
Zhou, J., Ahmad, F., Parikh, S., Hoffman, N. E., Rajan, S., Verma, V. K., Song, J., Yuan, A., Shanmughapriya, S., Guo, Y., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308544 · Cited by 103
Bang, D., Wilson, W., Ryan, M., Yeh, J. J., & Baldwin, A. S. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0541 · Cited by 101
Peineau, S., Nicolas, C. S., Bortolotto, Z. A., Bhat, R. V., Ryves, W. J., Harwood, A. J., Dournaud, P., Fitzjohn, S. M., & Collingridge, G. L. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-22 · Cited by 100
Wagner, F. F., Benajiba, L., Campbell, A. J., Weïwer, M., Sacher, J. R., Gale, J. P., Ross, L., Puissant, A., Alexe, G., Conway, A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam8460 · Cited by 98
The function of the RNA-binding protein hnRNP in cancer metastasis
Zhang, M., Han, N., & Li, W. (2013) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.122506 · Cited by 93
The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?
Bhat, R. V., Andersson, U., Andersson, S., Knerr, L., Bauer, U., & Sundgren-Andersson, A. K. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179934 · Cited by 93
Hagen, T., Di Daniel, E., Culbert, A. A., & Reith, A. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201364200 · Cited by 89
Phosphorylation of bovine neurofilament proteins by protein kinase FA (glycogen synthase kinase 3)
Guan, R. J., Khatra, B. S., & Cohlberg, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92971-6 · Cited by 85
Gambardella, A., Nagaraju, C. K., OʼShea, P., Mohanty, S. T., Kottam, L., Pilling, J. E., Sullivan, M., Djerbi, M., Koopmann, W., Croucher, P. I., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.266 · Cited by 79
Evidence for a new binding mode to GSK-3: Allosteric regulation by the marine compound palinurin
Bidon‐Chanal, A., Fuertes, A., Alonso, D. A., Pérez, D. I., Martínez, A., Luque, F. J., & Medina, M. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.12.014 · Cited by 77
Zhai, P., Gao, S., Holle, E., Yu, X., Yatani, A., Wagner, T. E., & Sadoshima, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705133200 · Cited by 76
GSK-3α/β kinases and amyloid production in vivo
Jaworski, T., Dewachter, I., Lechat, B., Gees, M., Kremer, A., Demedts, D., Borghgraef, P., Devijver, H., Kügler, S., Patel, S., et al. (2011) · Nature · doi:10.1038/nature10615 · Cited by 75
Gulen, M. F., Bulek, K., Xiao, H., Yu, M., Gao, J., Sun, L., Beurel, E., Kaidanovich-Beilin, O., Fox, P. L., DiCorleto, P. E., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.019 · Cited by 75
Oviedo-Boyso, J., Cortés-Vieyra, R., Huante-Mendoza, A., Yu, H. B., Valdez-Alarcón, J. J., Bravo-Patiño, A., Cajero-Juárez, M., Finlay, B. B., & Baizabal-Aguirre, V. M. (2011) · Infection and Immunity · doi:10.1128/iai.05303-11 · Cited by 75
Self-citationAhmad, F., Lal, H., Zhou, J., Vagnozzi, R. J., Yu, J. E., Shang, X., Woodgett, J. R., Gao, E., & Force, T. L. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.068 · Cited by 74
Maqbool, M., & Hoda, N. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170714141450 · Cited by 71
Bhattacharjee, R., Goswami, S., Dudiki, T., Popkie, A. P., Phiel, C. J., Kline, D., & Vijayaraghavan, S. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.124495 · Cited by 70
Zhou, J., Lal, H., Chen, X., Shang, X., Song, J., Li, Y., Kerkelä, R., Doble, B. W., MacAulay, K., DeCaul, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41407 · Cited by 69
Lal, H., Zhou, J., Ahmad, F., Zaka, R., Vagnozzi, R. J., DeCaul, M., Woodgett, J., Gao, E., & Force, T. (2012) · Circulation · doi:10.1161/circulationaha.111.050666 · Cited by 68
Guezguez, B., Almakadi, M., Benoit, Y. D., Shapovalova, Z., Rahmig, S., Fiebig‐Comyn, A., Casado, F. L., Tanasijevic, B., Bresolin, S., Masetti, R., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.11.012 · Cited by 68
Distinct expression and activity of GSK‐3α and GSK‐3β in prostate cancer
Darrington, R. S., Campa, V. M., Walker, M. M., Bengoa‐Vergniory, N., Gorroño‐Etxebarria, I., Onganer, P. U., Kawano, Y., Waxman, J. H., & Kypta, R. M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27620 · Cited by 63
Zhang, J.-S., Herreros-Villanueva, M., Koenig, A., Deng, Z., de Narvajas, A. A.-M., Gomez, T. S., Meng, X., Bujanda, L., Ellenrieder, V, Li, X. K., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.102 · Cited by 60
Dunning, C. J., McGauran, G., Willén, K., Gouras, G. K., O’Connell, D. J., & Linse, S. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00262 · Cited by 60
Azoulay‐Alfaguter, I., Yaffe, Y., Licht-Murava, A., Urbańska, M., Jaworski, J., Pietrokovski, S., Hirschberg, K., & Eldar-Finkelman, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127969 · Cited by 59
Extremely Tight Binding of Ruthenium Complex to Glycogen Synthase Kinase 3
Atilla‐Gokcumen, G. E., Pagano, N., Streu, C. N., Maksimoska, J., Filippakopoulos, P., Knapp, S., & Meggers, E. (2008) · ChemBioChem · doi:10.1002/cbic.200800489 · Cited by 57
Monte, F. L., Kramer, T., Gu, J., Anumala, U. R., Marinelli, L., Pietra, V. L., Novellino, E., Franco, B., Demedts, D., LEUVEN, F. V., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300309a · Cited by 53
Structure-based optimization of oxadiazole-based GSK-3 inhibitors
Monte, F. L., Kramer, T., Gu, J., Brodrecht, M., Pilakowski, J., Fuertes, A., Domínguez, J. M., Plotkin, B., Eldar-Finkelman, H., & Schmidt, B. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.06.006 · Cited by 53
Chaikuad, A., Diharce, J., Schröder, M., Foucourt, A., Leblond, B., Casagrande, A.-S., Désiré, L., Bonnet, P., Knapp, S., & Besson, T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01083 · Cited by 53
Hoffmann, H. M., Beumer, T. L., Rahman, S., McCabe, L. R., Banerjee, C., Aslam, F., Tiro, J. A., van Wijnen, A. J., Stein, J. L., Stein, G. S., et al. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960501)61:2<310::aid-jcb14>3.0.co;2-p · Cited by 53
Alon, L. T., Pietrokovski, S., Barkan, S., Avrahami, L., Kaidanovich-Beilin, O., Woodgett, J. R., Barnea, A., & Eldar-Finkelman, H. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.025 · Cited by 51
Carter, Y. M., Kunnimalaiyaan, S., Chen, H., Gamblin, T. C., & Kunnimalaiyaan, M. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28015 · Cited by 48
Glycogen synthase kinase-3: A potential preventive target for prostate cancer management
Li, B., Thrasher, J. B., & Terranova, P. F. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.05.006 · Cited by 46
Feyt, C., Kienlen-Campard, P., Leroy, K., N'Kuli, F., Courtoy, P. J., Brion, J.-P., & Octave, J.-N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501610200 · Cited by 46
Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis
Gao, F., Al‐Azayzih, A., & Somanath, P. R. (2015) · Oncotarget · doi:10.18632/oncotarget.3335 · Cited by 46
Transgenic Mouse Methods and Protocols
Hofker, M. H., & van Deursen, J. (2002) · Humana Press eBooks · doi:10.1385/1592593402 · Cited by 46
Chen, X. X., Wang, R., Liu, X., Wu, Y., Zhou, T., Yang, Y., Perez, A. A., Chen, Y.-C., Hu, L., Chadarevian, J. P., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.11.007 · Cited by 44
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Piazza, F., Manni, S., Tubi, L. Q., Montini, B., Pavan, L., Colpo, A., Gnoato, M., Cabrelle, A., Adami, F., Zambello, R., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-526 · Cited by 43
A Noncatalytic Domain of Glycogen Synthase Kinase-3 (GSK-3) Is Essential for Activity
Buescher, J. L., & Phiel, C. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091603 · Cited by 42
Maurin, H., Lechat, B., Dewachter, I., Ris, L., Louis, J. V., Borghgraef, P., Devijver, H., Jaworski, T., & Van Leuven, F. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-27 · Cited by 41
[36] Glycogen synthase kinase-3 from rabbit skeletal muscle
Hemmings, B. A., & Cohen, P. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)99069-9 · Cited by 40
GSK3α, not GSK3β, drives hippocampal NMDAR‐dependent LTD via tau‐mediated spine anchoring
Draffin, J. E., Sánchez‐Castillo, C., Fernández‐Rodrigo, A., Sánchez‐Sáez, X., Ávila, J., Wagner, F. F., & Esteban, J. A. (2021) · The EMBO Journal · doi:10.15252/embj.2020105513 · Cited by 39
Hu, S., Ueda, M., Stetson, L., Ignatz-Hoover, J., Moreton, S., Chakrabarti, A., Xia, Z., Karan, G., de Lima, M., Agrawal, M. K., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0566 · Cited by 38
Giambelluca, M. S., Bertheau-Mailhot, G., Laflamme, C., Rollet, E., Servant, M. J., & Pouliot, M. (2014) · The FASEB Journal · doi:10.1096/fj.14-251900 · Cited by 36
Shahab, L., Plattner, F., Irvine, E. E., Cummings, D. M., & Edwards, F. A. (2014) · Hippocampus · doi:10.1002/hipo.22362 · Cited by 35
Deletion of Myeloid GSK3α Attenuates Atherosclerosis and Promotes an M2 Macrophage Phenotype
McAlpine, C. S., Huang, A., Emdin, A. L., Banko, N. S., Beriault, D. R., Shi, Y., & Werstuck, G. H. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305438 · Cited by 35
Evaluation of Improved Glycogen Synthase Kinase-3α Inhibitors in Models of Acute Myeloid Leukemia
Neumann, T., Benajiba, L., Göring, S., Stegmaier, K., & Schmidt, B. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01200 · Cited by 35
mTORC1 Activation Promotes Spermatogonial Differentiation and Causes Subfertility in Mice
Wang, C., Wang, Z., Xiong, Z., Dai, H., Zou, Z., Jia, C., Bai, X., & Chen, Z. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.116.140947 · Cited by 35
Kühn, R., & Schwenk, F. (2003) · Humana Press eBooks · doi:10.1385/1-59259-340-2:159 · Cited by 33
Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia
Kuenzi, B. M., Rix, L. L. R., Kinose, F., Kroeger, J. L., Lancet, J. E., Padron, E., & Rix, U. (2019) · Scientific Reports · doi:10.1038/s41598-018-37174-6 · Cited by 33
GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis
Grassilli, E., Ianzano, L., Bonomo, S., Missaglia, C., Cerrito, M. G., Giovannoni, R., Masiero, L., & Lavitrano, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100947 · Cited by 32
Açıkgöz, E., Güler, G., Çamlar, M., Öktem, G., & Aktuğ, H. (2018) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2018.10.036 · Cited by 30
Rao, C. V., Farooqui, M., Madhavaram, A., Zhang, Y., Asch, A. S., & Yamada, H. Y. (2020) · Aging Cell · doi:10.1111/acel.13221 · Cited by 29
Park, S., Lee, J. W., Herbst, R. S., & Koo, J. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153075 · Cited by 28
Structural Plasticity of Dendritic Spines Requires GSK3α and GSK3β
Cymerman, I. A., Gozdz, A., Urbanska, M., Milek, J., Dziembowska, M., & Jaworski, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134018 · Cited by 27
Campa, V. M., Baltziskueta, E., Bengoa‐Vergniory, N., Gorroño‐Etxebarria, I., Wesołowski, R., Waxman, J., & Kypta, R. M. (2014) · Oncotarget · doi:10.18632/oncotarget.2303 · Cited by 26
Antagonistic role of GSK3 isoforms in glioma survival
Vashishtha, V., Jinghan, N., & Yadav, A. K. (2018) · Journal of Cancer · doi:10.7150/jca.21248 · Cited by 25
Wang, Y., Dou, X., Jiang, L., Jin, H., Zhang, L., Zhang, L., & Liu, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.039 · Cited by 24
Huang, K., Huang, Y., Li, P., He, B., Chen, Z., Xia, Y., Chen, J., Zhang, Q., Shi, H., & Shan, Y. (2013) · Hepatology Research · doi:10.1111/hepr.12256 · Cited by 23
Lee, T., Ho, Y., Yu, J., & Yang, S. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240580410 · Cited by 22
Maejima, Y., Galeotti, J., Molkentin, J. D., Sadoshima, J., & Zhai, P. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00415.2012 · Cited by 20
The association between Alzheimer's disease and cancer: Systematic review - Meta-analysis.
Papageorgakopoulos, T. N., Μoraitou, D., Papanikolaou, M., & Tsolaki, M. (2017) · PubMed · Cited by 20
Yang, S., Yu, J., Lee, T., Ni, M., Yang, C., Ho, Y., & Tsen, T. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590203 · Cited by 19
Flepisi, B. T., Lochner, A., & Huisamen, B. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-013-6467-8 · Cited by 18
Huisamen, B., Hafver, T. L., Lumkwana, D., & Lochner, A. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6665-2 · Cited by 18
Silva-García, O., Rico-Mata, R., Maldonado-Pichardo, M. C., Bravo-Patiño, A., Valdez-Alarcón, J. J., Aguirre-González, J., & Baizabal-Aguirre, V. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00092 · Cited by 15
Self-citationYang, C.-C., Hsu, C., Sheu, J. J., Mai, X.-Y., & Yang, S.-D. (1998) · Journal of Protein Chemistry · doi:10.1023/a:1022503215525 · Cited by 13
Yang, S. D., Yu, J., Yang, C., et al. (1996) · PubMed · doi:10.1002/(sici)1097-4644(19960501)61:2%3c238::aid-jcb7%3e3.0.co;2-v · Cited by 13
Yang, S., Yu, J., Yang, C., Lee, S., Lee, T., Ni, M., Kuan, C.-Y., & Chen, H.-C. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960501)61:2<238::aid-jcb7>3.0.co;2-v · Cited by 13
Cortés-Vieyra, R., Silva-García, O., Oviedo-Boyso, J., Huante-Mendoza, A., Bravo-Patiño, A., Valdez-Alarcón, J. J., Finlay, B. B., & Baizabal-Aguirre, V. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132867 · Cited by 11
Self-citationChronic valproic acid intoxication: reversal by naloxone
Thanacoody, R. H. K. (2007) · Emergency Medicine Journal · doi:10.1136/emj.2007.049791 · Cited by 11
Podocyte GSK3α is important for autophagy and its loss detrimental for glomerular function
Hurcombe, J., Lay, A. C., Ni, L., Barrington, A. F., Woodgett, J. R., Quaggin, S. E., Welsh, G. I., & Coward, R. J. (2019) · FASEB BioAdvances · doi:10.1096/fba.2019-00011 · Cited by 9
Cp, H., Sf, H., Cc, Y., & Langrish, V. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1133 · Cited by 8
Interferon-induced thrombotic microangiopathy
George, J. N. (2016) · Blood · doi:10.1182/blood-2016-10-742759 · Cited by 7
Management and treatment of lithium-induced nephrogenic diabetes insipidus
Finch, C. K., Brooks, T. W., Yam, P., & Kelley, K. W. (2005) · Therapy · doi:10.2217/14750708.2.4.669 · Cited by 6
Chronic valproic acid intoxication: reversal by naloxone: Table 1
Thanacoody, R. H. K. (2009) · BMJ Case Reports · doi:10.1136/bcr.06.2009.1924 · Cited by 1
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Interactomes of Glycogen Synthase Kinase-3 Isoforms
Cormier, K. W., Larsen, B. G., Gingras, A., & Woodgett, J. R. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00825 · Cited by 23
Wang, X., Shuai, W., Yang, P., Liu, Y., Zhang, Y., & Wang, G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102584 · Cited by 20
Targets and mechanisms of Alpinia oxyphylla Miquel fruits in treating neurodegenerative dementia
Zeng, P. H., Liu, Y.-C., Wang, X., Ye, C., Sun, Y., Su, H.-F., Qiu, S.-W., Li, Y., Wang, Y., Wang, Y., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1013891 · Cited by 18
Soltan, O. M., Abdelrahman, K. S., Bass, A. K. A., Takizawa, K., Narumi, A., & Konno, H. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107651 · Cited by 15
Metadata
- Authors
- Silva-García, O., Cortés-Vieyra, R., Mendoza-Ambrosio, F. N., Ramírez-Galicia, G., & Baizabal-Aguirre, V. M.
- Affiliations
- Universidad del Papaloapan (MX)
- Mexican Social Security Institute (MX)
- Departamento de Química Teórica, Universidad del Papaloapan, Oaxaca 68301, Mexico
- Centro Multidisciplinario de Estudios en Biotecnología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolás de Hidalgo, Michoacán 58893, Mexico
- Corresponding author
- Silva-García, Octavio
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-12-16
- Volume
- 10
- Issue
- 12
- Pages
- 1683
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC7765659
- OpenAlex
- W3112569863
- Cited by
- 17
- References
- 122
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 1
- FWCI
- 0.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Consejo Nacional de Ciencia y Tecnología
- Universidad Michoacana de San Nicolás de Hidalgo
- Instituto Mexicano del Seguro Social
- Coordinación de la Investigación Científica
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- GSK3α, glycogen synthase kinase-3, neurodegenerative diseases, Alzheimer's disease, cancer, kinase inhibitors, protein phosphorylation, enzyme redundancy
- MeSH terms
- Alzheimer Disease, Animals, Brain Neoplasms, Female, Humans, Lung Neoplasms, Male, Multiple Myeloma, Phosphorylation, Prostatic Neoplasms, Signal Transduction, Leukemia, Myeloid, Acute, Protein Serine-Threonine Kinases, HL-60 Cells, Neurodegenerative Diseases, Inhibitory Concentration 50, Carcinoma, Pancreatic Ductal, Glycogen Synthase Kinase 3, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.